Case Report
This report highlights a potential safety signal of dermatomyositis induced by atorvastatin.
Answers are grounded in this paper and cite their sources.
May support statin switch for suspected atorvastatin-induced dermatomyositis; leaves open generalizability from single case.
Department of Internal Medicine Naval Medical Center San Diego San Diego, CA [email protected] Department of Rheumatology Naval Medical Center San Diego San Diego, CA The authors declare no conflict of interest. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, or the US Government.
No takes yet. Share an insight, caveat, or question.
Spiro et al. (2018) conducted a case report in Dermatomyositis. Atorvastatin was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: